The effect of oral evening primrose oil on menopausal hot flashes: a randomized clinical trial
- 1.5k Downloads
Hot flashes are common experience for menopausal women, and for many, are severe enough to significantly compromise their overall sense of well being and quality of life. The aim of this study was to compare the efficacy of evening primrose with placebo in improvement of menopausal hot flashes.
In a 6-week randomized clinical trial, a total of 56 menopausal women aged 45–59 years were participated in this study. The patients were asked for their hot flashes characteristics and responded to HFRDIS (hot flash related daily interference scale) questionnaire before and after the intervention. The participants were randomly assigned to take two capsules per day (totally 90 capsules for 6 weeks) of placebo or evening primrose (500 mg) for continuous 6 weeks. Then, the improvement in hot flashes was compared between two groups.
The percent of improvement in hot flash frequency, severity and duration were 39, 42 and 19 %, in evening primrose group compared with 32, 32 and 18 % in placebo group, respectively. Although all three characters of hot flash was ameliorated in evening primrose arm, only its severity was significantly better in this arm compared with placebo group (P < 0.05). All HFRDIS score were significantly improved in two groups, but the percentage of improvement in social activities, relations with others, and sexuality was significantly superior to placebo group (P < 0.05).
The application of oral evening primrose oil compared with placebo for controlling hot flashes may decrease more the intensity of attacks as well as ameliorating the HFRDIS score.
KeywordsMenopause Hot flashes Evening primrose
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Gold EB, Block G, Crawford S, Lachance L, FitzGerald G, Miracle H, Sherman S (2004) Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the study of women’s health across the nation. Am J Epidemiol 159(12):1189–1199. doi: 10.1093/aje/kwh168 PubMedCrossRefGoogle Scholar
- 2.Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA 288(3):321–333PubMedCrossRefGoogle Scholar
- 6.Vestergaard P, Hermann AP, Stilgren L, Tofteng CL, Sorensen OH, Eiken P, Nielsen SP, Mosekilde L (2003) Effects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure––a randomised controlled study. Maturitas 46(2):123–132 pii: S0378512203001816PubMedCrossRefGoogle Scholar
- 8.Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J (2004) Conjugated equine estrogens and global cognitive function in postmenopausal women: women’s health initiative memory study. JAMA 291(24):2959–2968. doi: 10.1001/jama.291.24.2959 PubMedCrossRefGoogle Scholar
- 9.Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin replacement study (HERS) research group. JAMA 280(7):605–613PubMedCrossRefGoogle Scholar
- 11.National Institutes of Health (2005) National institutes of health state-of-the-science conference statement: management of menopause-related symptoms Ann Intern Med 142(12 Pt 1):1003–1013 [pii: 0000605-200506210-00117]Google Scholar
- 15.Bassey EJ, Littlewood JJ, Rothwell MC, Pye DW (2000) Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre and postmenopausal women: two randomized controlled trials of Efacal versus calcium alone. Br J Nutr 83(6):629–635 [pii: S0007114500000805]PubMedCrossRefGoogle Scholar
- 22.Loprinzi CL, Sloan J, Stearns V, Slack R, Iyengar M, Diekmann B, Kimmick G, Lovato J, Gordon P, Pandya K, Guttuso T Jr, Barton D, Novotny P (2009) Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol 27(17):2831–2837. doi: 10.1200/JCO.2008.19.6253 PubMedCrossRefGoogle Scholar
- 23.Loprinzi CL, Qin R, Balcueva EP, Flynn KA, Rowland KM Jr, Graham DL, Erwin NK, Dakhil SR, Jurgens DJ, Burger KN (2010) Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. J Clin Oncol 28(4):641–647. doi: 10.1200/JCO.2009.24.5647 PubMedCrossRefGoogle Scholar
- 24.Aidelsburger P, Schauer S, Grabein K, Wasem J (2012) Alternative methods for the treatment of post-menopausal troubles. GMS Health Technol Assess 8: Doc03. doi: 10.3205/hta000101
- 25.Bordeleau L, Pritchard KI, Loprinzi CL, Ennis M, Jugovic O, Warr D, Haq R, Goodwin PJ (2010) Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. J Clin Oncol 28(35):5147–5152. doi: 10.1200/JCO.2010.29.9230 PubMedCrossRefGoogle Scholar
- 26.Maclennan AH, Broadbent JL, Lester S, Moore V (2004) Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev (4): CD002978 doi: 10.1002/14651858.CD002978.pub2